Return-Path: <corrina@MIT.EDU>
Received: from grand-central-station.mit.edu by po11.mit.edu (8.9.2/4.7) id VAA01418; Sun, 28 Apr 2002 21:57:30 -0400 (EDT)
Received: from melbourne-city-street.mit.edu (MELBOURNE-CITY-STREET.MIT.EDU [18.7.21.86])
	by grand-central-station.mit.edu (8.9.2/8.9.2) with ESMTP id VAA02529
	for <nutso-flaming-pikans@mit.edu>; Sun, 28 Apr 2002 21:56:56 -0400 (EDT)
Received: from tsuga.mit.edu (TSUGA.MIT.EDU [18.214.0.120])
	by melbourne-city-street.mit.edu (8.9.2/8.9.2) with ESMTP id VAA22768
	for <nutso-flaming-pikans@mit.edu>; Sun, 28 Apr 2002 21:56:54 -0400 (EDT)
Message-Id: <5.0.2.1.2.20020428215729.01b950e0@hesiod>
X-Sender: corrina@hesiod (Unverified)
X-Mailer: QUALCOMM Windows Eudora Version 5.0.2
Date: Sun, 28 Apr 2002 21:58:55 -0400
To: nutso-flaming-pikans@mit.edu
From: Corrina <corrina@MIT.EDU>
Subject: a bad idea probably.
Mime-Version: 1.0
Content-Type: multipart/alternative;
	boundary="=====================_4758902==_.ALT"

--=====================_4758902==_.ALT
Content-Type: text/plain; charset="iso-8859-1"; format=flowed
Content-Transfer-Encoding: quoted-printable

a drug to support MIT lifestyle "choices"
-ccc

http://www.washingtonpost.com/ac2/wp-dyn/A60736-2002Apr27?language=3Dprinter
For Sleep-Deprived, a Dream Drug?
Doctors Question Use of Narcolepsy Medicine to Support Lifestyle Choice
By Shankar Vedantam
Washington Post Staff Writer
Sunday, April 28, 2002; Page A03
Merrill Mitler travels frequently, often sleeping consecutive days in=20
different time zones. When his body clock feels out of sync with his=20
schedule, he swallows a medicine that was approved to treat sleepiness=20
associated with a rare disorder he doesn't have.
Americans last year bought $150 million worth of the drug modafinil, which=
=20
was approved to treat narcolepsy, an unusual disorder that causes people to=
=20
fall asleep suddenly. Three-quarters of the pills were swallowed by people=
=20
who didn't have narcolepsy. Doctors are prescribing the drug to patients=20
with other disorders and, increasingly, to people with no disorder at all.
Three years after it was approved, the medicine is raising questions about=
=20
how many healthy Americans might soon want it simply to sleep less -- yet=20
another example of a medicine being used not to treat illness, but to=20
support a lifestyle choice.
Unlike amphetamines and conventional stimulants, modafinil does not give=20
people a jolt. Doctors believe it is not addictive and say it is generally=
=20
safe, with only occasional side effects such as headache or nausea. But no=
=20
one knows what might happen if people use the drug to do away with sleep=20
for prolonged periods.
"The biggest questions are societal," said Thomas Scammell, a neurologist=20
at Harvard Medical School. "What's to keep us from working 24-7? . . . To=20
take a drug and try to counter this natural necessity of sleep is to defy=20
nature. It's like if I can give you a pill to take away your appetite --=20
does it mean it's okay not to eat?"
The drug's manufacturer, Cephalon Inc. of West Chester, Pa., had promoted=20
it as effective for more than just narcolepsy. But after the Food and Drug=
=20
Administration charged in January that Cephalon's promotional materials=20
were "false, lacking in fair balance or otherwise misleading," the company=
=20
promised to limit its promotional pitches to narcolepsy. The company plans=
=20
eventually to present studies to the FDA that would expand the drug's=20
approval for sleepiness associated with a variety of psychiatric and=20
neurological disorders.
Studies are also underway to test whether modafinil can help healthy truck=
=20
drivers navigate night journeys and get to their destinations safely by=20
dawn. The military is investigating whether modafinil can help healthy=20
soldiers stay awake for lengthy periods in combat. A large trial is=20
studying the medicine's effectiveness among shift workers.
At one site of this study, the Scripps Research Institute in San Diego,=20
psychologist Mitler is evaluating whether modafinil can help people fight=20
their normal circadian rhythms. His use of the medicine suggests he knows=20
the result.
"Do you need a pill to treat a normal condition?" Mitler said. "There is=20
all sorts of precedent for that -- we take aspirin for sore muscles=20
associated with exercise. Muscles are supposed to hurt when they are not=20
trained. Yet we medicalize it in order to treat the discomfort."
"The side effects of caffeine are much more severe than the side effects of=
=20
modafinil," said Mitler, who believes that decisions about modafinil are=20
best left to individuals and their doctors.
Americans have long been fascinated by sleep -- or rather, with not=20
sleeping: Students glorify in tales of all-nighters; sleeping on the job=20
has often been grounds for getting fired; and the ultimate capitalist=20
utopia is the 24-hour workday.
A spokeswoman for Cephalon acknowledged that the company sought to expand=20
the market for modafinil beyond narcoleptics. Studies are showing that the=
=20
medicine, which is sold as Provigil, could help people with sleepiness=20
associated with depression, Parkinson's disease and other disorders, she=
 said.
"There are so many conditions where people have pathological sleepiness=20
where we can help them," said the spokeswoman, Sheryl Williams. "Can we=20
stop people from using the product for other things? Absolutely not, but=20
the right place to be is in treating serious medical problems."
Once a drug is approved for one use, doctors are free to prescribe it for=20
others. Williams said most of the medicine's "off-label" use was in=20
treating psychiatric and neurological conditions. "We have not seen in our=
=20
tracking data a significant proportion of patients with nonmedical=20
conditions," she said.
But treating sleepiness can blur the line between medical disorders and=20
lifestyle problems, since sleepiness is not a disorder. The shift workers=20
in Mitler's study, for example, are known to be at heightened risk for=20
accidents and to have increased medical problems associated with their=20
irregular sleep. But there may not be anything intrinsically wrong with=20
them since their problems often go away when they resume normal schedules.
Yet, doctors have classified sleep disturbances caused by the workers'=20
lifestyle as a disorder. The American Psychiatric Association, for=20
instance, says, "Circadian Rhythm Sleep Disorder" can occur when people's=20
"circadian sleep-wake cycle is normal" but there is a "conflict between the=
=20
pattern of sleep and wakefulness generated by the circadian system and the=
=20
desired pattern of sleep and wakefulness required by shift work."
"These individuals are impaired," Mitler said. "Whether you call it a=20
disorder or not is less important than the fact that they are impaired.=20
Physicians have found themselves in the mix simply by declaring this a=20
treatable disorder."
Cephalon eventually would like modafinil to be recognized as a treatment=20
for all sleepiness associated with any disorder. But in warning the company=
=20
about its promotional materials in January, the FDA noted that "Provigil is=
=20
not approved to treat such symptoms as sleepiness, tiredness, decreased=20
activity, lack of energy and fatigue."
"Provigil is indicated to improve wakefulness in patients with excessive=20
daytime sleepiness associated with narcolepsy," the FDA wrote to a senior=20
official at the company Jan. 3. "Provigil is not approved for use as a=20
daytime stimulant."
After Cephalon agreed to alter its marketing materials, the FDA considered=
=20
the matter resolved.
Notwithstanding the FDA's protests, there is every indication that=20
modafinil is effective in keeping healthy people awake. It may soon be=20
common for shift workers, soldiers and truck drivers to pop the pills=20
before embarking on long journeys or difficult projects.
Nancy Wesensten, a researcher at the Walter Reed Army Institute of Research=
=20
in Silver Spring, has shown that healthy people who have been kept awake=20
for 54 hours -- more than two nights -- still function effectively when=20
given modafinil. The drug seems to work on other species, too: At the=20
University of Pennsylvania, scientist Joan Hendricks has even found that=20
modafinil helps sleep-deprived fruit flies perk up.
"It has a much gentler effect on promoting wakefulness" than amphetamines=20
and conventional stimulants, said Scammell, the Harvard neurologist. "Many=
=20
people feel comfortably awake -- they don't feel wound up, jazzed or=20
euphoric. That's what makes it attractive to doctors. We are always worried=
=20
that amphetamines may not be used properly. The abuse potential [of=20
modafinil] is low."
He pointed out that the exact mechanism of modafinil is not understood. For=
=20
example, while many researchers believe that the medicine doesn't affect=20
the brain's dopamine system -- a neural mechanism known to underlie many=20
addictions -- this hasn't been conclusively demonstrated. About 1 in 10=20
people on modafinil have headaches, and smaller numbers feel some nausea,=20
he said.
Scammell, Mitler and others who study the medicine warn that talk of=20
replacing sleep altogether is foolish. Other chemicals have been similarly=
=20
touted -- and then found to be harmful.
"People were using [amphetamines] to stay awake for a number of days at a=20
time -- there were a lot of problems associated with that," said John=20
Caldwell, a research psychologist at the U.S. Army Aeromedical Research Lab=
=20
at Fort Rucker, Ala., who has conducted experiments to show that=20
sleep-deprived helicopter pilots perform better when given modafinil.
"Who knows what will happen with modafinil?" he said. "We don't know why=20
sleep has the restorative effect it does. Given we don't understand the=20
nature of sleep, I don't think it's a good idea to try to replace it with a=
=20
drug of any description."
=A9 2002 The Washington Post Company


---------------------------------------------------------------
-Corrina Chase

http://web.mit.edu/corrina/tpool/tidepool.html

--=====================_4758902==_.ALT
Content-Type: text/html; charset="iso-8859-1"
Content-Transfer-Encoding: quoted-printable

<html>
a drug to support MIT lifestyle &quot;choices&quot;<br>
<font face=3D"helvetica" color=3D"#FF0000"><b>-ccc<br>
<br>
<a=
 href=3D"http://www.washingtonpost.com/ac2/wp-dyn/A60736-2002Apr27?language=
=3Dprinter"=
 eudora=3D"autourl">http://www.washingtonpost.com/ac2/wp-dyn/A60736-2002Apr2=
7?language=3Dprinter<br>
</a></font><font size=3D5>For Sleep-Deprived, a Dream Drug?</b></font>
<br>
Doctors Question Use of Narcolepsy Medicine to Support Lifestyle Choice
<br>
By Shankar Vedantam<br>
Washington Post Staff Writer<br>
Sunday, April 28, 2002; Page A03 <br>
Merrill Mitler travels frequently, often sleeping consecutive days in
different time zones. When his body clock feels out of sync with his
schedule, he swallows a medicine that was approved to treat sleepiness
associated with a rare disorder he doesn't have.<br>
Americans last year bought $150 million worth of the drug modafinil,
which was approved to treat narcolepsy, an unusual disorder that causes
people to fall asleep suddenly. Three-quarters of the pills were
swallowed by people who didn't have narcolepsy. Doctors are prescribing
the drug to patients with other disorders and, increasingly, to people
with no disorder at all.<br>
Three years after it was approved, the medicine is raising questions
about how many healthy Americans might soon want it simply to sleep less
-- yet another example of a medicine being used not to treat illness, but
to support a lifestyle choice.<br>
Unlike amphetamines and conventional stimulants, modafinil does not give
people a jolt. Doctors believe it is not addictive and say it is
generally safe, with only occasional side effects such as headache or
nausea. But no one knows what might happen if people use the drug to do
away with sleep for prolonged periods.<br>
&quot;The biggest questions are societal,&quot; said Thomas Scammell, a
neurologist at Harvard Medical School. &quot;What's to keep us from
working 24-7? . . . To take a drug and try to counter this natural
necessity of sleep is to defy nature. It's like if I can give you a pill
to take away your appetite -- does it mean it's okay not to
eat?&quot;<br>
The drug's manufacturer, Cephalon Inc. of West Chester, Pa., had promoted
it as effective for more than just narcolepsy. But after the Food and
Drug Administration charged in January that Cephalon's promotional
materials were &quot;false, lacking in fair balance or otherwise
misleading,&quot; the company promised to limit its promotional pitches
to narcolepsy. The company plans eventually to present studies to the FDA
that would expand the drug's approval for sleepiness associated with a
variety of psychiatric and neurological disorders.<br>
Studies are also underway to test whether modafinil can help healthy
truck drivers navigate night journeys and get to their destinations
safely by dawn. The military is investigating whether modafinil can help
healthy soldiers stay awake for lengthy periods in combat. A large trial
is studying the medicine's effectiveness among shift workers.<br>
At one site of this study, the Scripps Research Institute in San Diego,
psychologist Mitler is evaluating whether modafinil can help people fight
their normal circadian rhythms. His use of the medicine suggests he knows
the result.<br>
&quot;Do you need a pill to treat a normal condition?&quot; Mitler said.
&quot;There is all sorts of precedent for that -- we take aspirin for
sore muscles associated with exercise. Muscles are supposed to hurt when
they are not trained. Yet we medicalize it in order to treat the
discomfort.&quot;<br>
&quot;The side effects of caffeine are much more severe than the side
effects of modafinil,&quot; said Mitler, who believes that decisions
about modafinil are best left to individuals and their doctors.<br>
Americans have long been fascinated by sleep -- or rather, with not
sleeping: Students glorify in tales of all-nighters; sleeping on the job
has often been grounds for getting fired; and the ultimate capitalist
utopia is the 24-hour workday.<br>
A spokeswoman for Cephalon acknowledged that the company sought to expand
the market for modafinil beyond narcoleptics. Studies are showing that
the medicine, which is sold as Provigil, could help people with
sleepiness associated with depression, Parkinson's disease and other
disorders, she said.<br>
&quot;There are so many conditions where people have pathological
sleepiness where we can help them,&quot; said the spokeswoman, Sheryl
Williams. &quot;Can we stop people from using the product for other
things? Absolutely not, but the right place to be is in treating serious
medical problems.&quot;<br>
Once a drug is approved for one use, doctors are free to prescribe it for
others. Williams said most of the medicine's &quot;off-label&quot; use
was in treating psychiatric and neurological conditions. &quot;We have
not seen in our tracking data a significant proportion of patients with
nonmedical conditions,&quot; she said.<br>
But treating sleepiness can blur the line between medical disorders and
lifestyle problems, since sleepiness is not a disorder. The shift workers
in Mitler's study, for example, are known to be at heightened risk for
accidents and to have increased medical problems associated with their
irregular sleep. But there may not be anything intrinsically wrong with
them since their problems often go away when they resume normal
schedules.<br>
Yet, doctors have classified sleep disturbances caused by the workers'
lifestyle as a disorder. The American Psychiatric Association, for
instance, says, &quot;Circadian Rhythm Sleep Disorder&quot; can occur
when people's &quot;circadian sleep-wake cycle is normal&quot; but there
is a &quot;conflict between the pattern of sleep and wakefulness
generated by the circadian system and the desired pattern of sleep and
wakefulness required by shift work.&quot;<br>
&quot;These individuals are impaired,&quot; Mitler said. &quot;Whether
you call it a disorder or not is less important than the fact that they
are impaired. Physicians have found themselves in the mix simply by
declaring this a treatable disorder.&quot;<br>
Cephalon eventually would like modafinil to be recognized as a treatment
for all sleepiness associated with any disorder. But in warning the
company about its promotional materials in January, the FDA noted that
&quot;Provigil is not approved to treat such symptoms as sleepiness,
tiredness, decreased activity, lack of energy and fatigue.&quot;<br>
&quot;Provigil is indicated to improve wakefulness in patients with
excessive daytime sleepiness associated with narcolepsy,&quot; the FDA
wrote to a senior official at the company Jan. 3. &quot;Provigil is not
approved for use as a daytime stimulant.&quot;<br>
After Cephalon agreed to alter its marketing materials, the FDA
considered the matter resolved.<br>
Notwithstanding the FDA's protests, there is every indication that
modafinil is effective in keeping healthy people awake. It may soon be
common for shift workers, soldiers and truck drivers to pop the pills
before embarking on long journeys or difficult projects.<br>
Nancy Wesensten, a researcher at the Walter Reed Army Institute of
Research in Silver Spring, has shown that healthy people who have been
kept awake for 54 hours -- more than two nights -- still function
effectively when given modafinil. The drug seems to work on other
species, too: At the University of Pennsylvania, scientist Joan Hendricks
has even found that modafinil helps sleep-deprived fruit flies perk
up.<br>
&quot;It has a much gentler effect on promoting wakefulness&quot; than
amphetamines and conventional stimulants, said Scammell, the Harvard
neurologist. &quot;Many people feel comfortably awake -- they don't feel
wound up, jazzed or euphoric. That's what makes it attractive to doctors.
We are always worried that amphetamines may not be used properly. The
abuse potential [of modafinil] is low.&quot;<br>
He pointed out that the exact mechanism of modafinil is not understood.
For example, while many researchers believe that the medicine doesn't
affect the brain's dopamine system -- a neural mechanism known to
underlie many addictions -- this hasn't been conclusively demonstrated.
About 1 in 10 people on modafinil have headaches, and smaller numbers
feel some nausea, he said.<br>
Scammell, Mitler and others who study the medicine warn that talk of
replacing sleep altogether is foolish. Other chemicals have been
similarly touted -- and then found to be harmful.<br>
&quot;People were using [amphetamines] to stay awake for a number of days
at a time -- there were a lot of problems associated with that,&quot;
said John Caldwell, a research psychologist at the U.S. Army Aeromedical
Research Lab at Fort Rucker, Ala., who has conducted experiments to show
that sleep-deprived helicopter pilots perform better when given
modafinil.<br>
&quot;Who knows what will happen with modafinil?&quot; he said. &quot;We
don't know why sleep has the restorative effect it does. Given we don't
understand the nature of sleep, I don't think it's a good idea to try to
replace it with a drug of any description.&quot;<br>
<div align=3D"center">
=A9 2002 The Washington Post Company <br>
<br>
<x-sigsep><p></x-sigsep>
</div>
---------------------------------------------------------------<br>
-Corrina Chase<br>
<br>
<a href=3D"http://web.mit.edu/corrina/tpool/tidepool.html"=
 eudora=3D"autourl">http://web.mit.edu/corrina/tpool/tidepool.html</a><br>
</html>

--=====================_4758902==_.ALT--

